Effect Of DAAs For Treatment Of HCV On Normal Kidney
NCT03296930
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Antiviral Drug Adverse Reaction
Interventions
DRUG:
Sofosbuvir 400 MG Oral Tablet,
DRUG:
Ombitasvir/paritaprevir/ritonavir
Sponsor
Assiut University